Steven Lichtman
Stock Analyst at William Blair
(4.79)
# 545
Out of 5,044 analysts
1013
Total ratings
53.1%
Success rate
14.6%
Average return
Main Sectors:
Stocks Rated by Steven Lichtman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OWLT Owlet | Reiterated: Buy | n/a | $4.73 | - | 2 | Sep 25, 2026 | |
| BFLY Butterfly Network | Reiterated: Buy | n/a | $8.25 | - | 2 | Sep 15, 2026 | |
| BBNX Beta Bionics | Reiterated: Hold | n/a | $17.63 | - | 2 | Sep 14, 2026 | |
| MMED MiniMed Group | Reiterated: Buy | n/a | $19.71 | - | 5 | Sep 14, 2026 | |
| COO The Cooper Companies | Downgraded: Hold | n/a | $54.37 | - | 32 | Sep 12, 2026 | |
| SYK Stryker | Reiterated: Buy | n/a | $277.33 | - | 54 | Sep 9, 2026 | |
| TNDM Tandem Diabetes Care | Initiated Coverage: Buy | n/a | $16.11 | - | 44 | Aug 21, 2026 | |
| ENOV Enovis | Reiterated: Buy | n/a | $17.69 | - | 3 | Aug 14, 2026 | |
| SWX: ALC Alcon Inc. | Rated: Hold | n/a | $53.14 | - | 8 | Aug 12, 2026 | |
| RXST RxSight | Reiterated: Hold | n/a | $4.81 | - | 16 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.89 | - | 4 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $89.14 | - | 73 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $135.28 | - | 65 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $84.11 | - | 90 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $165.69 | - | 16 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $15 | $3.29 | n/a | 22 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $118 | $42.73 | n/a | 81 | Aug 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $7.5 | $11.77 | n/a | 22 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $73 → $78 | $74.65 | n/a | 69 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $87 → $116 | $87.21 | n/a | 14 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $16 | $11.52 | n/a | 6 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $275 | $319.40 | n/a | 1 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $21.67 | n/a | 5 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $92 → $94 | $88.48 | n/a | 146 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $13.44 | n/a | 123 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.5 | $2.72 | n/a | 3 | Sep 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0002 | n/a | 17 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.29 | n/a | 15 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.39 | n/a | 8 | Dec 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.49 | n/a | 13 | Dec 18, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $237 | $282.43 | n/a | 1 | Feb 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.94 | n/a | 11 | May 27, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.689 | n/a | 26 | Mar 4, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.521 | n/a | 13 | Mar 13, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.11 | n/a | 1 | Oct 7, 2011 |
Owlet
Sep 25, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.73
Upside: -
Butterfly Network
Sep 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $8.25
Upside: -
Beta Bionics
Sep 14, 2026
Reiterated: Hold
Price Target: n/a
Current: $17.63
Upside: -
MiniMed Group
Sep 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $19.71
Upside: -
The Cooper Companies
Sep 12, 2026
Downgraded: Hold
Price Target: n/a
Current: $54.37
Upside: -
Stryker
Sep 9, 2026
Reiterated: Buy
Price Target: n/a
Current: $277.33
Upside: -
Tandem Diabetes Care
Aug 21, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $16.11
Upside: -
Enovis
Aug 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $17.69
Upside: -
Alcon Inc.
Aug 12, 2026
Rated: Hold
Price Target: n/a
Current: $53.14
Upside: -
RxSight
Aug 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $4.81
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $8.89
Upside: -
Aug 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $89.14
Upside: -
Aug 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $135.28
Upside: -
Jul 31, 2026
Reiterated: Buy
Price Target: n/a
Current: $84.11
Upside: -
Jul 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $165.69
Upside: -
Sep 5, 2025
Reiterated: Buy
Price Target: $12 → $15
Current: $3.29
Upside: n/a
Aug 3, 2025
Reiterated: Hold
Price Target: $118
Current: $42.73
Upside: n/a
May 14, 2025
Reiterated: Buy
Price Target: $11 → $7.5
Current: $11.77
Upside: n/a
May 9, 2025
Reiterated: Hold
Price Target: $73 → $78
Current: $74.65
Upside: n/a
Feb 26, 2025
Reiterated: Buy
Price Target: $87 → $116
Current: $87.21
Upside: n/a
Jan 10, 2025
Reiterated: Buy
Price Target: $13 → $16
Current: $11.52
Upside: n/a
Dec 16, 2024
Initiated Coverage: Buy
Price Target: $275
Current: $319.40
Upside: n/a
Nov 1, 2024
Reiterated: Hold
Price Target: n/a
Current: $21.67
Upside: n/a
Aug 21, 2024
Reiterated: Hold
Price Target: $92 → $94
Current: $88.48
Upside: n/a
May 7, 2024
Downgraded: Hold
Price Target: n/a
Current: $13.44
Upside: n/a
Sep 19, 2023
Reiterated: Buy
Price Target: $3.5
Current: $2.72
Upside: n/a
Feb 6, 2023
Rated: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a
Aug 10, 2022
Downgraded: Hold
Price Target: n/a
Current: $1.29
Upside: n/a
Dec 31, 2020
Rated: Hold
Price Target: n/a
Current: $2.39
Upside: n/a
Dec 18, 2018
Rated: Hold
Price Target: n/a
Current: $6.49
Upside: n/a
Feb 8, 2018
Reiterated: Buy
Price Target: $237
Current: $282.43
Upside: n/a
May 27, 2016
Reiterated: Hold
Price Target: n/a
Current: $2.94
Upside: n/a
Mar 4, 2016
Downgraded: Hold
Price Target: n/a
Current: $0.689
Upside: n/a
Mar 13, 2015
Downgraded: Hold
Price Target: n/a
Current: $0.521
Upside: n/a
Oct 7, 2011
Downgraded: Hold
Price Target: n/a
Current: $1.11
Upside: n/a